Exclusive dermatology updates brought to you by the Journal of Drugs in Dermatology (JDD) online editorial team. Stay up-to-date on dermatology and aesthetic news, conference coverage, featured articles and more.
JDD Online News
Dive into JDD’s hair resources! You told us you wanted more on hair, so JDD listened. Hair disorders—from everyday androgenetic hair loss to the disruptive, emotionally fraught cases of alopecia…
Inhaled, Applied, Prescribed: Steroids Through the Allergy Lens Guest: Dr. Bob Geng We all reach for corticosteroids—whether it's that trusty tube, inhaler, or systemic burst (or maybe all of the…
Have you read this JDD consensus on advanced topical nonsteroidal therapies for atopic dermatitis? Dive into this recent article from the March issue! A seven-dermatologist expert panel used a structured…
Have you read this JDD consensus on advanced topical nonsteroidal therapies for atopic dermatitis? A recent retrospective analysis using the TriNetX research network compared patients with non scarring hair loss…
GLP-1 Receptor Agonist Use and Hidradenitis Suppurativa in Overweight Patients — Retrospective Findings from a Single Center Have you read this article in the latest JDD issue? A recent IRB-exempt…
From the Vault: In this article from JDD, a multi state BRFSS analysis finds higher skin cancer history in rural populations and In this article from the JDD vault, authors…
Have you read this JDD case report on combination therapy for dissecting cellulitis of the scalp? Have you read this article in JDD? This case report describes two men, ages…
Check out our all-new JDD Video Abstract from Benjamin Ungar MD, who discusses Molecular Insights: Immune and Barrier Dysregulation in Seborrheic Dermatitis.
JDD study on biologics and cardiometabolic Dive into this March article! A large retrospective analysis using the TriNetX research network examined adults with hidradenitis suppurativa who were treated with biologics…
Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features David Ciocon MD, one of the co-authors of “Racial Disparities in Un ited States Clinical Trial Enrollment for…
From the Vault: Noninvasive RNA from Tape Strips Differentiates AK from SCC In this article from the JDD vault, authors report a single center study that used adhesive tape strips…
A comparative evaluation finds promising concordance but highlights gaps that require In the February JDD, authors compared two large language models, ChatGPT and DeepSeek, against the 2021 American Academy of…
Retrospective JDD study finds minocycline or doxycycline (100 mg twice daily) led to meaningful improvement in inflammatory gingival OLP in two months In a recent JDD report of 254 biopsy‑confirmed…
Lilly published the results of a Phase 3b clinical trial that showed treatment with concomitant Taltz (ixekizumab) and Zepbound (tirzepatide) was superior to ixekizumab alone in patients with active psoriatic…
In this article from JDD: Excimer laser delivers measurable PASI gains but evidence is limited A JDD meta‑analysis of 308 nm excimer laser treatment for plaque psoriasis pooled four clinical…
A JDD retrospective review links generalized disease to higher comorbidity burden and reports favorable response to pentoxifylline In this article from JDD’s February 2026’s issue, authors present a single center,…
Curated by the JDD Editors Missed any of our February highlights? February is packed with intriguing articles, and you’ll want to start to dive in! Catch up with this curated…
Behind the Bottle Part Deux: A Scientific, Socratic Squawk on Sensitive and Susceptible Skin Guest: Dr. Peter Lio The JDD Podcast returns with Part 2 of "Behind the Bottle", hosted…
From the Vault: A JDD survey of dermatology residents highlights concerns among underrepresented groups that may influence interest in Mohs micrographic surgery and dermatologic oncology fellowships In this article from…
Check out our all-new JDD Video Abstract from Seemal R. Desai, MD who discusses Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation.
Practical imaging security for dermatologists: encryption, secure storage, metadata hygiene and device protocols In this Letter to the Editor published in the February issue of the Journal of Drugs in…
Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features Aaron S. Farberg MD FAAD, one of the co-authors of “Cutaneous Adverse Events Associated With GLP-1 Receptor Agonists:…
Public health messaging misses the mark on Monkeypox and HIV A cross‑jurisdiction survey of publicly available Monkeypox and HIV materials from state, large metropolitan and select non‑metro U.S. health departments…
Ten Years, One Live Celebration: Join the conversation We were proud to celebrate a remarkable milestone at ODAC 2026, held January 16-19, 2026. It was a fitting place to honor…
In skin of color, halo phenomena can mask benign lesions; biopsy and dermoscopic‑pathologic correlation remain essential It’s time to dive into one of our January JDD case reports ! A…
Barrier boost for acne care: A new gel moisturizer soothes, strengthens and lifts quality of life We’re highlighting a December 2025 article that features one of JDD’s most sought-after topics:…
Aesthetics Is Changing. Here’s What We’re Seeing? Most dermatologists have experienced a shift in patient preferences over the past several years. There is a shift toward a minimalist, natural appearance.…
Trials fall short on representation - Black patients underenrolled in MF/SS studies The February issue of JDD features a review of completed US interventional trials for mycosis fungoides and Sézary syndrome…
Case report shows dual IL‑17A/F blockade produced striking clinical and functional gains within one month in refractory ACH The February 2026 JDD issue features a case report about a 67‑year‑old…
Combined Relabotulinum Toxin A frontalis modulation with NASHA™ gel skinboosters for the temples yields natural‑looking wrinkle softening and lasting skin quality gains beyond six months The Oncoderm Resource Center on…
Medscape highlighted a January Journal of Drugs in Dermatology study on the incidence of skin and hair effects from GLP-1 agonists. The study, “Cutaneous Adverse Events Associated With GLP-1 Receptor…
Case report: six weeks of gentian violet and trichloroacetic acid peel produced marked healing in dominant dystrophic epidermolysis bullosa with minimal discomfort The February 2026 JDD issue features a case…
Combined Relabotulinum Toxin A frontalis modulation with NASHA™ gel skinboosters for the temples yields natural‑looking wrinkle softening and lasting skin quality gains beyond six months A preliminary clinical series tested…
From the Vault: Review of the last decade finds biological rationale for skin and hair benefits, yet no FDA approvals and major gaps in standardization and clinical data Dive into…
Curated by the JDD Editors Missed any of our January highlights? January is our Aesthetics issue and it’s packed with intriguing articles–start to dive in! Catch up with this curated…
Systematic review finds Astragalus membranaceus compounds offer photoprotection, collagen support and even telomere benefits, but larger trials are needed A PRISMA systematic review of studies from 2015-2025 highlights growing preclinical…
2024 Asia‑Pacific survey of 204 Thermage users finds ideal candidates in their 40s, rising confidence, common same‑day combos with injectables, and practical tips on tips, settings and safety InA 2024…
Case Report: Rare post‑booster pigment change - photodistributed hyperpigmentation reported after COVID‑19 vaccination Dive into one of JDD’s latest case reports ! A 70‑year‑old woman developed a diffuse blue‑grey, photodistributed…
From the Vault: Vitiligo trials lag on diversity - US studies underrepresent non‑White and Hispanic patients We are pulling this article from the JDD vault. It’s a July 2024 article…
Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features Kseniya Kobets MD MHS, one of the co-authors of “Disparities in Hidradenitis Suppurativa Clinical Trials: An Updated Review…
Medscape featured a December Journal of Drugs in Dermatology study on the link between isotretinoin and inflammatory bowel disease (IBD). The study, “Isotretinoin Does Not Increase the Risk of Inflammatory…
Analysis of the top 50 Instagram posts finds physician content more reliable but represents only a quarter of popular posts In one of our January JDD articles, it focuses on…
From the Vault: PLLA‑SCA injections deliver durable cheek wrinkle improvement and high patient satisfaction We are highlighting one of our popular articles from the vault: a January 2024 read that…
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Title: Novel Treatments and Clinical Insights Shaping Dermatology As we head into the new year, it’s important to highlight some of the pieces that helped clarify the role of novel…
See JDD author Dr. Andrew Blauvelt bring cutting‑edge psoriasis science to life in GWU’s Dermatology Translational Science Lecture Series, and learn about his new Nature study on high‑induction risankizumab dosing.…
Check out our all-new JDD Video Abstract from Joshua Zeichner MD, who discusses Retrospective Review of Dermal Safety Studies of Organic Sunscreens.
Thiamidol shows rapid, sustained benefit for facial hyperpigmentation We’re highlighting a December 2025 article that we’re sure you’ll want to dive into! A 90‑patient randomized study found that thiamidol formulations…
Join Dr. Jared Jagdeo, a board certified dermatologist, to learn more about new innovations of SkinCeuticals. Dr. Jagdeo will present a review of the latest antioxidant science from SkinCeuticals. Faculty…
Join Dr. Ted Lain, Chief Medical Officer at Sanova Dermatology, and Star Walsh, R&D Director at Neutrogena®, for an informative webinar on the latest science and role of adjunctive OTC…
Coverage clears the way: Most large private insurers pay for Botox and friends for axillary hyperhidrosis In one of our January JDD articles, we reviewed public medical‑policy guidance from the…
Despite millennia of observation and modern understanding of HPV, treatment choices remain trade‑offs between efficacy, speed and tolerability From the Editor-in-Chief Dear Readers, As we look back on 2025, one…
Behind all sunscreen is a scientific story, the photobiology, toxicology and public perception. Yet, the science often gets lost in the noise of misconceptions and outdated narratives. Join Adam Friedman…
Minocycline ER spares the microbiome: A December JDD highlight In the December issue of JDD we wanted to highlight a randomized, double‑blind, placebo‑controlled microbiome study of DFD‑29 (minocycline hydrochloride extended‑release…
From the Vault: Fecal transplant may revive immunotherapy responses in melanoma We pulled this February 2024 vault article because it’s been a popular read. It’s a focused review of microbiota‑modulating…
Metabolic drugs for HS? GLP‑1 receptor agonists show promise beyond weight loss If you haven’t yet, dig into this recent JDD article about GLP-1 receptor agnosists and hidradenitis suppurativa. Hidradenitis…
Isotretinoin and IBD — large real‑world data offer reassurance In one of our recent JDD articles, a retrospective cohort using the TriNetX network compared acne patients exposed to long‑term, low‑dose…
Review highlights higher psychiatric comorbidity, systemic barriers to care, and the value of integrated psychodermatologic models This article in the December 2025 issue of JDD discusses how Hispanic and Latinx…
Now arrived for recently graduated dermatologists: the JDD Welcome Kit! The Journal of Drugs in Dermatology (JDD), together with generous sponsors, has sent these curated kits to the newest members…
Background: The objective of this survey was to obtain feedback and insights from United States dermatology healthcare professionals on their perceptions of sunscreens. Methods: This cross-sectional survey study launched online…
Join Dr. Zoe Diana Draelos, MD, as she presents data on over-the-counter product innovations from L'Oréal Dermatological Beauty's trusted brands: CeraVe and La Roche-Posay Dr. Draelos will discuss Xerosis Management…
Don’t lose platelets to the gel: simple tweaks boost PRP yield from thixotropic systems We are pulling out this must-read article from the vault. This brief report from the November…
Lessons learned from a challenging lived experience is a terrible thing to waste…which is why we would NEVER do so! In this episode of the JDD Podcast's Steroid Stewardship Series,…
Despite millennia of observation and modern understanding of HPV, treatment choices remain trade‑offs between efficacy, speed and tolerability Warts are caused by non‑enveloped double‑stranded DNA human papillomaviruses and, while two‑thirds…
Representation improving but not solved—Black patients still underrepresented in recent HS trials A review of ClinicalTrials.gov trials for hidradenitis suppurativa initiated between June 2020 and December 2024 identified five trials…
Case report: IL‑31 receptor blockade markedly reduced neuropathic pruritus and improved quality of life in a 52‑year‑old woman after standard therapies failed Scarring reflects replacement of normal dermis by fibroblast-driven,…
Navigating the New Dermatology Landscape: Billing, Virtual Care, and the Rise of DermTok In the past several years, managing and running a dermatology practice has changed drastically. These changes have…
Review places silicone and occlusion as first‑line topical therapy, with retinoids, pressure, corticosteroids and cannabinoids as situational tools amid limited high‑quality evidence Scarring reflects replacement of normal dermis by fibroblast-driven,…
Efficient history, targeted exam, selective labs and clear shared‑decision plans let dermatologists deliver meaningful vitiligo care in time‑pressed visits In routine practice, non‑segmental vitiligo (NSV) visits can be both brief…
Background: Psoriasis is a common skin condition that affects the physical and emotional well-being of patients. Moisturizers have been shown to significantly improve skin condition and quality of life in…
Case Report: Peristomal Pyoderma Gangrenosum After Colectomy — A Clinical Reminder for Dermatologists This JDD Case Report dives into how a 55‑year‑old woman developed rapidly progressive, painful cribriform ulcers with…
In Field (Cancerization) Tested: Patient and Provider Perspectives on Klisyri, guest host Dr. Vishal A. Patel, Associate Professor of Dermatology and Medicine/Oncology at the George Washington University School of Medicine…
What patients eat matters in HS: pro‑inflammatory diets worsen disease; anti‑inflammatory patterns and targeted supplements may help This literature review synthesizes recent studies connecting dietary patterns with hidradenitis suppurativa severity.…
Case report shows symptom improvement with 1.5% ruxolitinib cream after standard therapies failed A 72‑year‑old woman with refractory Benign Familial Pemphigus (Hailey‑Hailey disease) experienced persistent flares despite conventional management with…
From the Vault: A popular consensus paper recommends newborn‑to‑child barrier care with ceramide‑containing moisturizers to delay flares and reduce steroid need We pulled this widely read JDD article because it…
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Curated by the JDD Editors Missed any of our November highlights? November is packed with intriguing articles–start to dive in! Catch up with this curated roundup from the JDD Editors—your…
From the Vault: Fecal microbiota transplant may revive ICI responses in metastatic melanoma We went into the JDD vault to highlight a focused review of microbiota‑modulating interventions in metastatic melanoma treated…
Dermatology HCPs overwhelmingly back practical sunscreens — social media blamed for most misinformation A cross‑sectional online survey of 723 U.S. dermatology healthcare professionals via the Dermsquared platform probed perceptions of…
Mohs proves highly effective for female genital skin cancers - pooled review reports ~95% cure A targeted systematic review of the literature identified 166 treated cases of extramammary Paget’s disease,…
Check out our all-new JDD Video Abstract from Zoe Diana Draelos, MD, who discusses Skin Barrier Benefits of a Natural Moisturizing Factor and Lipids-Based Moisturizer for Clinically Sensitive Skin.
Check Out Our Latest TSLS The field of dermatology continues to evolve at a rapid pace, bringing groundbreaking research from the lab to the clinic. As part of its ongoing…
Corticosteroids have been the effective, accessible, and familiar backbone of dermatologic therapy for decades. But with great power comes great responsibility. In this episode, podcast host Dr. Adam Friedman, Professor…
Niacinamide still useful — but high oral doses may carry cardiovascular risk A literature review confirms that oral nicotinamide (niacinamide) is a versatile, generally well‑tolerated tool in dermatology: it reduces…
L’Oréal Dermatological Beauty: Discover What’s New & Next in OTC Care from CeraVe and La Roche-Posay
Join Seemal Desai, MD, FAAD, as he presents the latest over-the-counter product innovations from L'Oréal Dermatological Beauty's trusted brands: CeraVe and La Roche-Posay. Dr. Desai will present new clinical and…
Ranked As A Top 10 Dermatology Podcast The JDD podcast, hosted by Dr. Friedman, was recently ranked as a top ten dermatology podcast by Feedspot. We are grateful for the…
Caffeine shows promise for hair loss, but evidence remains preliminary A systematic review identified nine studies—five randomized controlled trials, three prospective cohorts and one twin‑twin cohort—evaluating caffeine interventions for hair…
Breakthroughs in atopic dermatitis are redefining treatment from the inside out. Discover how new data on race, microbes, and patient preferences are transforming the way we think about AD. In…
Barrier boost with benefits - new topical cream raises filaggrin, hyaluronic acid and lipids while improving tolerability A novel topical cream moisturizer produced meaningful biological and clinical improvements in both…
Exosome complex after microneedling shows promising hair‑regrowth signals in a 30‑patient series In a 30‑subject study (15 men, 15 women; mean age 50.2 years) treated with an Exosome Regenerative Complex+…
Think beyond inflammation: SAIGE framing reframes pediatric AD prevention and care A seven‑expert global panel of pediatric dermatologists and dermatologists used a modified Delphi process to produce five consensus statements…
Dupilumab delivers — but many patients need more than monotherapy over time In a US retrospective cohort (OM1 PremiOM™ AD) of 5,200 patients who started dupilumab between 2017-2021 (208 children, 430…
Join Dr. Kachiu Lee, a board-certified cosmetic dermatologist, to learn more about new innovations of SkinCeuticals. Dr. Lee will share the latest integrated skincare science from SkinCeuticals, focusing on products…
Topical Steroid Withdrawal — What Your Patients Are Watching Online Topical steroid withdrawal (TSW) is an increasingly visible — and misunderstood — drug‑related dermatosis that can follow abrupt discontinuation of…
Rethinking AD — Beyond Inflammation Atopic dermatitis remains common and stubborn, especially in pediatric patients, because inflammation is only one part of a self‑reinforcing loop that includes microbiome disruption, neuroimmune…
Meet Dr. Theodore (Ted) J. Daly Theodore (Ted) J. Daly MD has been in private practice at Garden City Dermatology, New York, for nearly four decades. He received his medical…
From the Vault: Novel Strategy for Strengthening Dermatoporotic Skin by Managing Cellular Senescence
Microdosed Actives Target Dermal Senescence - A Surprising Lab Advance That Could Reshape Dermatoporosis Care Dermatoporosis —age‑related thinning and fragility of the skin driven by fibroblast dysfunction, ECM breakdown, and…
Influenza Vaccination and Arm Nodules: Uncovering a Hidden Risk A large propensity-matched cohort study using TriNetX data found that intramuscular influenza vaccination carries a 32% higher risk of developing subcutaneous…
Sunscreen ... our daily epi/dermal defense, our solar safeguard, our broad-spectrum BFF for life. Yet lurking in the shaded areas are unfounded fears: “Sunscreen causes cancer; Sunscreen is an endocrine…
Dermatology On-Call Data Uncover Trends in Hematology–Oncology Cutaneous Complications Oncodermatology consults for hematological malignancy patients often uncover therapy-related skin toxicities that can derail cancer treatment. In a retrospective review of…
